Interpreting Non-Inferiority Across Effect Scales: A Bayesian Perspective with Clinical Translation.

Ther Innov Regul SciMay 14, 2026 (epub)
Clinical ResearchPediatricsOpen access

Danila Azzolina, Silvia Bressan, Mohd Rashid Khan et al.

✦ AI-curated · Sources linked

In 30 seconds

This study conducted a secondary Bayesian reanalysis of a randomized controlled trial comparing high-flow nasal cannula (HFNC) and non-invasive ventilation (NIV) in infants with acute bronchiolitis. The analysis revealed that a non-inferiority margin of 0.15 in absolute risk reduction could imply a doubling of intubation odds, with a Number Needed to Harm of approximately 6.7.

Key findings

  • The Bayesian reanalysis indicated that a 0.15 non-inferiority ARR margin might imply a doubling of the odds of intubation.
  • The Number Needed to Harm (NNH) for HFNC compared to NIV was approximately 6.7.
  • The original analysis concluded non-inferiority using a fixed absolute margin.

Why it matters

Understanding the implications of non-inferiority margins is crucial for clinicians when interpreting trial results, as these margins can significantly affect treatment decisions and patient outcomes.

Source

Published in Ther Innov Regul Sci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.